The FDA has approved an expanded indication for Entresto (sacubitril/valsartan), from Novartis, to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with… read more.
Article written by Bruce Sylvester Pediatric proton pump inhibitor (PPI) treatment appears to be related to an increased risk of asthma in children, researchers reported on Feb. 8…. read more.
Interview and article written by Christine Clark With advancing age many people now look forward to a future in which digital solutions will support effective self-management and independent… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
